Contrast Media Injectors Market Is Expected To Reach US$ 959.8 Mn By 2026

The latest market report published by Credence Research, Inc. “Global Contrast Media Injectors Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global contrast media injectors market was valued at US$ 532.8 Mn in 2017, and is expected to reach US$ 959.8 Mn by 2026, expanding at a CAGR of 6.8% from 2018 to 2026.

Market Insights

Contrast media is injected in the human body by the injectors to enhance the quality of medical images in order to perform preliminary diagnosis and conduct visually aided minimally invasive surgeries. There have been several technical advancement in the contrast media injectors market such as automated injectors which control the amount of contrast media used and reduce the contrast waste. IT enabled injectors are being manufactured that determine patient dose by garnering information from picture archiving and communication system (PACS) and electronic medical record (EMR).

Injector systems are dominating the products segment on account of key factors such as increasing demand for computed tomography (CT) and magnetic resonance imaging (MRI) scans. Manufacturers are providing double head injectors and automated contrast media injectors to promote accuracy, enhance image quality and patient safety. Consumables will be showcasing impressive growth due to availability of diverse range of products at low cost and frequent replacement of tubings and syringes to prevent severe adverse events such as air embolism and extravasation.

Interventional cardiology is currently dominating the applications segment on account of factors such as rising prevalence of cardiovascular disorders. According to Center for Disease Control and Prevention (CDC) nearly 1 in 3 deaths in United States is caused by heart attack and stroke. Approximately 200,000 deaths can be prevented by early interventional cardiology. Radiology will register significant growth during the forecast period owing to factors such as increasing number of outpatients performing preliminary diagnosis and technical advancement in the clinical radiology saving time and money.

Download Free brochure of research report with TOC and Figures @

The key players manufacturing contrast media injector systems and consumables are APOLLO RT Co., Ltd., Sino Medical-Device Technology Co., Ltd, Bayer Healthcare LLC, GE Healthcare, Guerbet Group, Medtron AG, VIVID IMAGING, Nemoto Kyorindo Co., Ltd., Bracco Group and Ulrich GmbH & Co., KG.

Showing 1 reaction

Please check your e-mail for a link to activate your account.